Chitinase-3 like-protein-1 function and its role in diseases

T Zhao, Z Su, Y Li, X Zhang, Q You - Signal transduction and targeted …, 2020 - nature.com
Abstract Non-enzymatic chitinase-3 like-protein-1 (CHI3L1) belongs to glycoside hydrolase
family 18. It binds to chitin, heparin, and hyaluronic acid, and is regulated by extracellular …

Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis

B Bellaver, JP Ferrari-Souza, L Uglione da Ros… - Neurology, 2021 - AAN Enterprises
Objective To perform a systematic review and meta-analysis to determine whether fluid and
imaging astrocyte biomarkers are altered in Alzheimer disease (AD). Methods PubMed and …

Glial activation and inflammation along the Alzheimer's disease continuum

K Nordengen, BE Kirsebom, K Henjum… - Journal of …, 2019 - Springer
Background Neuronal and glial cell interaction is essential for synaptic homeostasis and
may be affected in Alzheimer's disease (AD). We measured cerebrospinal fluid (CSF) …

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

F Llorens, K Thüne, W Tahir, E Kanata… - Molecular …, 2017 - Springer
Background YKL-40 (also known as Chitinase 3-like 1) is a glycoprotein produced by
inflammatory, cancer and stem cells. Its physiological role is not completely understood but …

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

M Ewers, G Biechele, M Suárez‐Calvet… - EMBO molecular …, 2020 - embopress.org
Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's
disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a …

[HTML][HTML] The roles of inflammation and immune mechanisms in Alzheimer's disease

LJ Van Eldik, MC Carrillo, PE Cole, D Feuerbach… - Alzheimer's & Dementia …, 2016 - Elsevier
Abstract The Alzheimer's Association's Research roundtable met in April 2015 to explore the
role of neuroinflammatory mechanisms in the progression of Alzheimer's disease (AD). The …

The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease

Y Jung, JS Damoiseaux - Brain, 2024 - academic.oup.com
Over the past several years, there has been a surge in blood biomarker studies examining
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease

CL Sutphen, L McCue, EM Herries, C Xiong… - Alzheimer's & …, 2018 - Elsevier
Introduction Individuals in early stages of Alzheimer's disease are a targeted population for
secondary prevention trials aimed at preserving normal cognition. Understanding within …

Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives

F Li, A Liu, M Zhao, L Luo - Journal of Neurochemistry, 2023 - Wiley Online Library
Abstract Chitinase‐3‐like protein 1 (CHI3L1) is a secreted glycoprotein characterized by its
ability to regulate multiple biological processes, such as the inflammatory response and …

GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of Alexander disease

L Li, E Tian, X Chen, J Chao, J Klein, Q Qu, G Sun… - Cell stem cell, 2018 - cell.com
Alexander disease (AxD) is a leukodystrophy that primarily affects astrocytes and is caused
by mutations in the astrocytic filament gene GFAP. While astrocytes are thought to have …